Trending Stock News

Fny Managed Accounts Has Decreased By $1.84 Million Its Johnson & Johnson Ord (Call) (JNJ) Stake; Trinity Place Holdings (TPHS)’s Sentiment Is 1.06

Johnson & Johnson (NYSE:JNJ) Logo

Trinity Place Holdings Inc (TPHS) investors sentiment decreased to 1.06 in Q4 2017. It’s down -0.87, from 1.93 in 2017Q3. The ratio turned negative, as 19 hedge funds started new or increased stock positions, while 18 sold and reduced equity positions in Trinity Place Holdings Inc. The hedge funds in our database now have: 18.50 million shares, down from 18.57 million shares in 2017Q3. Also, the number of hedge funds holding Trinity Place Holdings Inc in top ten stock positions increased from 1 to 2 for an increase of 1. Sold All: 6 Reduced: 12 Increased: 16 New Position: 3.

Fny Managed Accounts Llc decreased Johnson & Johnson Ord (Call) (JNJ) stake by 99.46% reported in 2017Q4 SEC filing. Fny Managed Accounts Llc sold 14,044 shares as Johnson & Johnson Ord (Call) (JNJ)’s stock declined 9.21%. The Fny Managed Accounts Llc holds 76 shares with $10,000 value, down from 14,120 last quarter. Johnson & Johnson Ord (Call) now has $333.23 billion valuation. The stock increased 0.31% or $0.39 during the last trading session, reaching $124.24. About 5.43M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since May 20, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Since February 15, 2018, it had 0 buys, and 1 insider sale for $20.17 million activity. $20.17 million worth of Johnson & Johnson (NYSE:JNJ) was sold by Stoffels Paulus on Thursday, February 15.

Investors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It improved, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Moreover, Panagora Asset Mgmt has 0.74% invested in Johnson & Johnson (NYSE:JNJ) for 1.42M shares. Manchester Ltd Liability Com holds 22,345 shares or 0.46% of its portfolio. Moreover, Chickasaw Cap Management Limited has 0.16% invested in Johnson & Johnson (NYSE:JNJ). Barrett Asset Mngmt Lc, a New York-based fund reported 279,819 shares. Virginia-based Greylin Investment Mangement has invested 3.81% in Johnson & Johnson (NYSE:JNJ). High Pointe Cap Lc invested 0.74% in Johnson & Johnson (NYSE:JNJ). Tirschwell Loewy holds 3.89% or 197,339 shares. Intact Inv Mngmt reported 0.39% in Johnson & Johnson (NYSE:JNJ). First Amer Bank & Trust has 61,392 shares. Illinois-based Vaughan David Invests Il has invested 1.87% in Johnson & Johnson (NYSE:JNJ). Tru Department Mb Finance Bankshares N A, Illinois-based fund reported 120,440 shares. Groesbeck Invest Nj, a New Jersey-based fund reported 2,000 shares. Edgar Lomax Va reported 1.03% stake. Chatham Capital Gru Inc reported 57,562 shares or 2.21% of all its holdings. 109,299 are owned by Invest House.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 100 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was upgraded by Jefferies to “Buy” on Wednesday, October 11. The stock has “Sell” rating by BTIG Research on Friday, July 21. Piper Jaffray reinitiated it with “Neutral” rating and $105.0 target in Monday, October 5 report. The firm earned “Sell” rating on Friday, May 20 by Standpoint Research. Atlantic Securities downgraded Johnson & Johnson (NYSE:JNJ) on Friday, July 21 to “Sell” rating. Barclays Capital maintained it with “Equal-Weight” rating and $148 target in Wednesday, October 18 report. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, October 18. On Wednesday, July 20 the stock rating was upgraded by Argus Research to “Buy”. Citigroup maintained Johnson & Johnson (NYSE:JNJ) rating on Monday, October 23. Citigroup has “Buy” rating and $149 target. RBC Capital Markets maintained the shares of JNJ in report on Wednesday, October 7 with “Outperform” rating.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.05 earnings per share, up 12.02% or $0.22 from last year’s $1.83 per share. JNJ’s profit will be $5.50 billion for 15.15 P/E if the $2.05 EPS becomes a reality. After $2.06 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -0.49% negative EPS growth.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: which released: “Johnson & Johnson (NYSE:JNJ) Heffx Stock Technicals” on May 18, 2018, also with their article: “Johnson & Johnson: Waiting On The Wave” published on May 11, 2018, published: “Johnson & Johnson Sells Off After Earnings” on April 22, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: and their article: “Johnson & Johnson (JNJ) Consumer and Medical Devices Business Review – Brokers Conference Transcript” published on May 17, 2018 as well as‘s news article titled: “Johnson & Johnson Commits to Yet Another Dividend Hike” with publication date: April 26, 2018.

Price Michael F holds 3.73% of its portfolio in Trinity Place Holdings Inc. for 4.32 million shares. Marcato Capital Management Lp owns 3.82 million shares or 2.43% of their US portfolio. Moreover, Third Avenue Management Llc has 1.63% invested in the company for 4.89 million shares. The New York-based Kahn Brothers Group Inc De has invested 1.06% in the stock. Bulldog Investors Llc, a New Jersey-based fund reported 150,493 shares.

The stock increased 2.31% or $0.16 during the last trading session, reaching $7.1. About 19,609 shares traded or 15.27% up from the average. Trinity Place Holdings Inc. (TPHS) has 0.00% since May 20, 2017 and is . It has underperformed by 11.55% the S&P500.

Trinity Place Holdings Inc., a real estate holding, investment, and asset management company, owns, invest in, manages, develops, and/or redevelops real estate assets and/or real estate related securities in the United States. The company has market cap of $224.56 million. The firm focuses on the monetization of commercial real estate properties and controls intellectual property assets focused on the consumer sector. It currently has negative earnings. The Company’s principal asset is located at 77 Greenwich Street in Lower Manhattan.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *